Leading Patent Attorney David Dykeman discusses how medtech funding is at an all-time high, so optimizing your company’s patent portfolio is paramount. Patents are the new currency! In addition, intellectual property (IP) are the keys to the castle and must secure and control it across global partnerships, collaboration and change.
How a Strategic Patent Portfolio and Secure IP Help MedTech Companies Grow
Episode 4: David Dykeman (Greenberg Traurig)
Product Success Podcast: Quality and Medical Devices
September 16, 2021